The role of GxP compliance for safety and integrity
GxP compliance encompasses regulatory and quality guidelines such as Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP) established primarily by the FDA to ensure the safety, efficacy, traceability, and integrity of life science products and their supporting data throughout all stages of development, manufacturing, control, storage, and distribution, with specific requirements varying by product type and country.
GxP compliance is a series of regulatory and quality guidelines created to ensure that life science products are safe and that the integrity of supporting data is upheld and maintained. Compliance with GxP helps to ensure the traceability, accountability, and integrity of the data supporting life science products and services.
GxP compliance is important to maintain the process quality throughout each stage of product development including manufacturing, control, storage, and distribution.
There are also product-specific requirements that life science organizations are required to follow, depending on the type of product and the country in which products are being sold.
With the fundamental purpose of GxP requirements being to ensure that food and medical products are safe for consumers, they are initially determined by the Food and Drug Administration (FDA), which also oversees ongoing regulation.
What does GxP stand for?
The FDA identifies compliance-related activities as:
- G: Good
- x: Variable
- P: Practices
These good practices are related to a range of compliance activities, including:
-
Good Manufacturing Practices (GMP): GMP addresses cleanliness and hygiene, valid process usage, handling complaints, record keeping, and personnel qualifications. GMP takes required and proactive measures to ensure the safety and efficacy of products. GMP guidelines also allow manufacturers to easily understand how to best implement them in their respective specific environments.
-
Good Laboratory Practices (GLP): GLP mandates targets to ensure the repeatability, uniformity, reliability, quality, and integrity of human and animal health products through safety tests in research laboratories. The key principles of GLP — tested under a certified QMS system — include risk management, organization, and responsibilities.
-
Good Clinical Practices (GCP): GCP is a global standard monitored by the International Conference on Harmonization (ICH) and focuses on the morality of clinical trials. The ICH stipulates that the interests of corporations are not prioritized over human life in clinical trials when using human subjects. ICH also assures this approach is followed when conducting clinical trials.
Related
Prioritizing Data Integrity in R&D: Challenges and Best Practices
The article emphasizes the critical importance of maintaining data integrity in R&D by implementing robust data governance, security, and management practices throughout the research lifecycle to ensure data accuracy, protect patient safety, uphold product efficacy, and comply with regulatory standards amid increasing digitization and evolving threats.
Modern Electronic Laboratory Notebooks
Modern electronic laboratory notebooks (ELNs) are software tools that enhance traditional physical lab notebooks by providing secure, centralized, and accessible platforms for data entry, protocol management, collaboration, and specialized laboratory functions, thereby improving data management, auditing, and resource tracking in research environments.
Why OneNote Falls Short as a Scientific Lab Notebook — and What to Use Instead
The article explains that while Microsoft OneNote is a convenient and low-cost note-taking tool some researchers use as a makeshift electronic laboratory notebook (ELN), it lacks essential scientific data management features, built-in validation, and structured organization, making it risky and unreliable for accurately capturing, labeling, and searching experimental research data.
Laboratory Compliance: Key Regulations and Automation
Laboratory compliance involves adhering to regulations set primarily by the U.S. Department of Health and Human Services' Office of the Inspector General, along with the FDA and DEA, requiring clinical labs to implement comprehensive policies and procedures—including standards of conduct to prevent fraud and waste, ensuring medical necessity of tests, regular review of standing orders, addressing OIG fraud alerts, and maintaining proper record retention—to ensure ethical, professional, and efficient laboratory operations.
What Is Data Integrity?
Data integrity refers to the accuracy, reliability, and consistency of data, which is essential for effective data-driven decision-making and can be maintained through organizational awareness, quality verification procedures, and protection against errors and external threats.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.